Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Becton, Dickinson and Company (BDX) has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England developing self-adhesive surgical sealant films. Tissuemed's lead product, Tissuepatch, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions.


RTTNews | Dec 9, 2021 07:02AM EST

07:02 Thursday, December 9, 2021 (RTTNews.com) - Becton, Dickinson and Company (BDX) has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England developing self-adhesive surgical sealant films. Tissuemed's lead product, Tissuepatch, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions.

Kevin Kelly, president of Surgery for BD, said: "Integrating Tissuepatch into our business aligns with our commitment to continuously innovate in our core portfolio to help support minimally invasive surgeries."

The company said the acquisition expands its global offerings for surgeons outside of the U.S. It expects transaction to be immaterial to fiscal 2022 results.

Read the original article on RTTNews ( https://www.rttnews.com/3248102/bd-buys-tissuemed-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC